[Radiation-induced hemorrhagic cystitis-possible treatment options!]

Area of Science:

• Urology
• Oncology
• Radiation Oncology

Background:

• Radiation-induced hemorrhagic cystitis (RIHC) is a significant late complication following pelvic radiation therapy.
• It affects approximately 5-10% of patients and can range from mild hematuria to life-threatening hemorrhage.

Purpose of the Study:

• To outline the clinical presentation and management strategies for radiation-induced hemorrhagic cystitis.
• To provide an overview of treatment options based on hematuria severity and persistence.

Main Methods:

• Review of clinical presentation and diagnostic considerations, including ruling out infection or malignancy.
• Description of sequential management approaches from conservative measures to invasive procedures.

Main Results:

• Mild to moderate hematuria may be managed with hydration to prevent clots.
• Emergency interventions include clot evacuation, continuous bladder irrigation, and transurethral fulguration.
• Persistent bleeding may require intravesical agents, hyperbaric oxygen, embolization, or surgical options.

Conclusions:

• Effective management of RIHC requires a stepwise approach tailored to symptom severity.
• Early and appropriate interventions can mitigate complications and improve patient outcomes.
• Refractory cases may necessitate advanced treatments like urinary diversion or cystectomy.